At Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons and highly specialized cells, the gut communicates with our brain to regulate important aspects of physiology and behavior, and multiple diseases have been linked to defects in this communication. Targeting the gut-brain axis — the bi-directional information highway between our gut and our brain — offers an unprecedented opportunity to access and influence brain centers involved in fundamental human processes and diseases of high unmet need.

Founded and headquartered in New York City, we have developed an industry-leading platform to harness the gut-brain axis. Our cross-disciplinary biotechnology team is integrating cutting-edge technologies in sequencing, computational biology, neural imaging, cellular and molecular biology, and human genetics to provide an understanding of gut-brain biology that, when coupled with our deep drug discovery expertise, will lead to transformational therapeutics to improve human health.